S Ruggieri Selected Research

S Ruggieri Research Topics

Disease

16	Parkinson Disease (Parkinson's Disease) 01/2009 - 01/2000
3	Multiple Sclerosis 06/2015 - 04/2014
3	Huntington Disease (Huntington's Disease) 06/2002 - 01/2001
2	Dyskinesias (Dyskinesia) 01/2009 - 03/2007
2	Hypothermia 06/2002 - 04/2001
1	Multiple Myeloma 03/2016
1	Relapsing-Remitting Multiple Sclerosis 04/2014
1	Atrophy 12/2011
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 07/2010
1	Substance-Related Disorders (Drug Abuse) 01/2009
1	Cognitive Dysfunction 10/2004
1	Larva Migrans (Cutaneous Larva Migrans) 05/2003
1	Infections 05/2003
1	Necrosis 06/2001
1	Parkinsonian Disorders (Parkinsonism) 04/2001
1	Movement Disorders (Movement Disorder) 12/2000
1	Hemolytic Anemia 08/2000
1	Multiple System Atrophy 01/2000
1	Melanoma (Melanoma, Malignant) 01/2000
1	Carcinoma (Carcinomatosis) 01/2000
1	Neoplasms (Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

7	Levodopa (L Dopa)FDA LinkGeneric 01/2009 - 12/2000
4	Dopamine (Intropin)FDA LinkGeneric 01/2009 - 04/2001
4	Apomorphine FDA Link 06/2002 - 02/2001
3	Methamphetamine (Desoxyn)FDA LinkGeneric 10/2004 - 04/2001
2	Fas Ligand Protein (Fas Ligand)IBA 06/2015 - 05/2015
2	NeurotoxinsIBA 10/2004 - 04/2001
2	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 10/2004 - 06/2002
2	Pramipexole (Mirapex)FDA LinkGeneric 04/2003 - 09/2002
2	ropinirole (Requip)FDA LinkGeneric 09/2002 - 03/2001
2	Dopamine Agonists (Dopamine Agonist)IBA 09/2002 - 03/2001
1	Bortezomib (Velcade)FDA Link 03/2016
1	Natalizumab (Tysabri)FDA Link 04/2014
1	CreatineIBA 12/2011
1	N-acetylaspartate (N-acetyl aspartate)IBA 12/2011
1	Riluzole FDA LinkGeneric 07/2010
1	Neurotransmitter Agents (Neurotransmitter)IBA 03/2007
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 03/2007
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2006
1	alpha-SynucleinIBA 01/2006
1	Pergolide (Permax)FDA Link 02/2005
1	AntibodiesIBA 05/2003
1	AntigensIBA 05/2003
1	Cabergoline FDA LinkGeneric 09/2002
1	Haloperidol (Haldol)FDA LinkGeneric 06/2002
1	Proteins (Proteins, Gene)FDA Link 06/2001
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2001
1	Neuroprotective AgentsIBA 04/2001
1	Olanzapine (Zyprexa)FDA Link 01/2001
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2001
1	Biomarkers (Surrogate Marker)IBA 01/2001
1	Therapeutic UsesIBA 12/2000
1	nucleotidaseIBA 08/2000
1	pyrimidineIBA 08/2000
1	LipidsIBA 01/2000
1	Platelet Activating FactorIBA 01/2000
1	WEB 2086 (apafant)IBA 01/2000

Therapy/Procedure

4	Therapeutics 07/2010 - 09/2002
1	Transcranial Magnetic Stimulation 08/2001
1	Catheters 01/2000